January AI is a technology company.
January AI has raised $9.0M across 1 funding round.
January AI has raised $9.0M in total across 1 funding round.
January AI has raised $9.0M in total across 1 funding round.
January AI's investors include 645 Ventures, AME Cloud Ventures, Broadway Angels, DFJ, Felicis Ventures, FJ Labs, Flex Capital, Foundry Group, Granatus Ventures, Greylock, Hardware Club, High Alpha.
January AI is a health technology company building AI-powered tools that turn complex health data into personalized, actionable insights for metabolic health. At its core, the company has developed a predictive glucose monitoring (PGM) system that uses artificial intelligence to forecast blood glucose curves without requiring continuous glucose monitors (CGMs), making metabolic insights accessible to a much broader population. Its consumer-facing app enables users to log meals via photo or text, receive real-time nutritional analysis, and get personalized guidance on food, activity, and habits to improve metabolic wellbeing.
The company serves both consumers and health platforms: individuals seeking to prevent or manage prediabetes and type 2 diabetes, and enterprise partners (including health plans, employers, and digital health platforms) looking to integrate precision nutrition and metabolic health tools via API. January AI solves the problem of reactive, generic health advice by delivering proactive, clinically grounded, biomarker-informed coaching that adapts to the individual. With strong early traction—including peer-reviewed research, an award-winning product, and growing adoption in the diabetes and metabolic health space—January AI is emerging as a leader in AI-driven preventive care.
---
January AI was founded by Noosheen Hashemi, a former executive at Hewlett-Packard and early-stage tech investor, who became deeply interested in the potential of machine learning to transform healthcare after attending Stanford’s MedicineX conference. Inspired by the idea of “consumerizing” healthcare and putting individuals at the center of their own health journey, she co-founded January AI with Mike Snyder, a renowned genomics and systems biology expert at Stanford. Their vision was to use multiomic data and predictive AI to make precision health practical, scalable, and accessible.
The idea crystallized around metabolic health, particularly the growing crisis of prediabetes and type 2 diabetes in the U.S. Recognizing that most people lack access to real-time glucose data and personalized nutrition guidance, the team set out to build a software-based solution that could predict glucose responses using AI, without requiring invasive hardware. Early validation came through clinical studies and presentations at major medical conferences like ADA 2020, which helped establish credibility and attract partners and users. This scientific foundation, combined with a consumer-first product approach, laid the groundwork for January AI’s evolution from a startup into a precision health platform trusted by both individuals and health organizations.
---
---
January AI sits at the intersection of several powerful trends reshaping healthcare and wellness: the rise of AI in medicine, the consumerization of health, and the growing focus on metabolic health as a foundation for longevity. With an estimated 136 million Americans at risk for diabetes, there is massive demand for accessible, data-driven prevention tools—especially as GLP-1 drugs bring metabolic health into the mainstream spotlight.
The company is riding the wave of AI’s ability to extract signal from noisy, real-world health data, turning everything from food photos to step counts into clinically meaningful insights. At the same time, it reflects a broader shift from reactive, episodic care to continuous, proactive health management powered by software. By making precision nutrition and glucose prediction available without expensive hardware, January AI is helping democratize a category that has historically been limited to high-cost, device-dependent solutions.
In the broader ecosystem, January AI is influencing how digital health platforms think about personalization: not just as a UX enhancement, but as a clinical imperative. Its API-first approach also positions it as an infrastructure layer for the next generation of health apps, wearables, and employer/insurer wellness programs that want to embed metabolic intelligence without rebuilding it from scratch.
---
January AI is poised to become a foundational layer in the future of personalized, preventive health. As metabolic health becomes a central pillar of wellness and longevity, the demand for scalable, AI-driven nutrition and glucose guidance will only grow. The company’s next phase will likely involve deeper clinical integrations, expanded biomarker modeling (beyond glucose), and broader adoption across health plans, employers, and care delivery systems.
Key trends shaping its journey include the mainstreaming of AI in healthcare, regulatory and reimbursement shifts around digital therapeutics, and increasing consumer appetite for data-driven, proactive health tools. If January AI continues to combine rigorous science with intuitive product design, it could move beyond being a “glucose app” to becoming a core operating system for metabolic health—one that powers everything from consumer wellness apps to clinical diabetes prevention programs.
Just as early fintech companies turned complex financial data into simple, actionable insights, January AI is doing the same for metabolic health: turning health data into real-world impact, one meal at a time.
January AI has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Venture Round in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2021 | $9.0M Venture Round | 645 Ventures, AME Cloud Ventures, Broadway Angels, DFJ, Felicis Ventures, FJ Labs, Flex Capital, Foundry Group, Granatus Ventures, Greylock, Hardware Club, High Alpha, LiveOak Venture Partners, Maverick Capital, Race Capital, Redpoint Ventures, Sapphire Ventures, SignalFire, Social Starts, Thrive Capital, Underdog Labs, Underscore VC, Adam D'Angelo, Brad Garlinghouse, Charlie Songhurst, Chris Wang, Dan Springer, Kevin Lin, Marek Olszewski, Mike Liu, Rebecca Minkoff, Russell Fradin, Russ Fradin |